GMO goats can produce ‘blockbuster’ cancer drug in their milk, which could slash prices for patients

| | June 17, 2020
goat jpg
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Goats can be genetically modified to produce a common cancer drug in their milk, which could slash its production costs.

Many of the new blockbuster drugs that are used as cancer treatments are more expensive than older medicines, because they are complex proteins called monoclonal antibodies that are complicated to make.

The bowel cancer drug cetuximab, for example, is produced by mouse cells that have been genetically engineered to make a specific monoclonal antibody. This expensive manufacturing process means the drug, which is sold under the name Erbitux ….

Read the original post (Behind paywall)

Related article:  GMO houseplant traps carcinogenic chemicals that home air filters miss
Advertisements
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend